Meridian Wealth Management LLC raised its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,204 shares of the financial services provider’s stock after acquiring an additional 130 shares during the period. Meridian Wealth Management LLC’s holdings in CME Group were worth $512,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Truvestments Capital LLC purchased a new stake in shares of CME Group in the 3rd quarter valued at about $26,000. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares during the last quarter. Dunhill Financial LLC increased its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners bought a new position in shares of CME Group during the 4th quarter valued at about $32,000. Finally, Fortitude Family Office LLC increased its position in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
Shares of CME stock opened at $254.48 on Thursday. The firm has a market cap of $91.70 billion, a P/E ratio of 26.32, a P/E/G ratio of 6.76 and a beta of 0.57. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $258.78. The business’s 50 day moving average price is $239.35 and its 200-day moving average price is $230.06. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.
CME Group announced that its board has authorized a stock buyback plan on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
Insider Transactions at CME Group
In related news, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of CME Group stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the sale, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,076 shares of company stock worth $4,271,496. 0.30% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
CME has been the topic of several recent research reports. Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Oppenheimer increased their price objective on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Royal Bank of Canada increased their price objective on CME Group from $235.00 to $269.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. Morgan Stanley increased their price objective on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Citigroup lowered CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $236.13.
View Our Latest Analysis on CME
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- How to Short Nasdaq: An Easy-to-Follow Guide
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Use the MarketBeat Dividend Calculator
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How to Choose Top Rated Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.